Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT01975831 |
| Title | A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Ludwig Institute for Cancer Research |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Yale Cancer Center | New Haven | Connecticut | 06510 | United States | Details | |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| Roswell Park Cancer Institute | Buffalo | New York | 14203 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| Mary Crowley Cancer Research Center | Dallas | Texas | 75230 | United States | Details | |
| University of Virginia Division of Hematology and Oncology | Charlottesville | Virginia | 22903 | United States | Details |